Cai’s group followed an interesting paper-based strategy in 2019 for simultaneous detection of tumor biomarkers called carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) in clinical samples [96]. The gene discussed is CEACAM5; the disease is neoplasm.